(210) | Number of the EPO application | 18721632 |
(220) | Filing date of the EPO application | 2018.04.13 |
(80) | EPO patent specification publication (B) | EPB nr. 06/2024, 2024.02.07 |
(110) | EPO patent number | 3609886 |
(11) | Number of the document | MD 3609886 T2 |
(21) | Number of the application | e 2020 0193 |
(71) | Name(s) of applicant(s), code of the country | BIOGEN MA INC., US; |
(72) | Name(s) of inventor(s), code of the country | HOPKINS Brian T., US; MA Bin, US; PRINCE Robin, US; MARX Isaac, US; LYSSIKATOS Joseph P., US; ZHENG Fengmei, US; PETERSON Matthew, US; PATIENCE Daniel B., US; |
(73) | Name(s) of owner(s), code of the country | BIOGEN MA INC., US; |
(54) | Title of the invention | Benzoazepine analogs as inhibiting agents for Bruton's tyrosine kinase |
(13) | Kind-of-document code | T2 |
(51) | International Patent Classification | C07D 413/14 (2006.01.01); A61K 31/44 (2006.01.01); A61K 31/443 (2006.01.01); A61K 31/506 (2006.01.01); C07D 403/14 (2006.01.01); C07D 471/04 (2006.01.01); A61P 25/02 (2006.01.01); A61P 35/00 (2006.01.01) |
(19) | Country | US |
(41) | Date of publication of the application | 2020.03.31 |
(49) | Date of publication of the translation of the validated European patent specification | 2024.07.31 |
(30) | Priority | 201762485745 P, 2017.04.14, US |
(74) | Patent attorney | (Procedură) FOCŞA Valentin, bd. Renaşterii Naţionale, No. 6, of. 08, MD-2024, mun. Chişinău, Republica Moldova |
(86) | International application | PCT/US2018/027415, 2018.04.13 |
(87) | International publication | WO 2018/191577, 2018.10.18 |